Related Experiment Videos
Reducing risk of cardiovascular events in noncardiac surgery
Enrico Passamonti1, Salvatore Pirelli
1Division of Cardiology, Istituti Ospitalieri di Cremona, Vl Concordia 1, 26100 Cremona, Italy. epassamonti@tin.it
Insights
Preventive coronary artery revascularization before noncardiac surgery offers no short-term benefit. Optimizing medical therapy, particularly beta-blockers, is key to reducing perioperative cardiac risks in stable patients.
Area of Science:
- Cardiology
- Anesthesiology
- Perioperative Medicine
Background:
- Cardiac adverse events are a significant complication in noncardiac surgery.
- Previous understanding of preventive coronary artery revascularization (CAR) benefits before noncardiac surgery has been updated.
- Optimizing medical therapy is crucial for managing perioperative cardiac risk.
Purpose of the Study:
- To review the evidence supporting the use of beta-blockers in reducing cardiac risk during noncardiac surgery.
- To discuss the pharmacological effects and practical application of beta-blockers in this context.
- To identify the remaining challenges in managing patients undergoing noncardiac surgery with cardiac concerns.
Main Methods:
- Review of existing studies on beta-blocker efficacy in noncardiac surgery.
- Analysis of pharmacological effects of beta-blockers.
- Discussion of practical aspects and patient selection for perioperative cardiac management.
Main Results:
- Short-term preventive coronary artery revascularization (CAR) does not reduce postoperative myocardial infarction, deaths, or hospital stay.
- CAR should be reserved for patients with an independent, well-defined need for the procedure.
- Beta-blocker therapy is strongly supported by evidence for reducing cardiac risk and may obviate the need for preoperative stress testing in many patients.
- Statin therapy may be considered for surgical candidates with known or suspected coronary disease.
Conclusions:
- Optimizing medical therapy, especially beta-blockers, is the primary strategy for reducing perioperative cardiac complications in stable patients undergoing noncardiac surgery.
- Coronary artery revascularization decisions should be independent of the noncardiac surgery indication.
- Further research is needed for cost-effective identification of patients who may require revascularization despite beta-blocker therapy.
Abstract:
Cardiac adverse events are a major cause of complications in noncardiac surgery. The benefit of preventive coronary artery revascularisation in stable patients before noncardiac surgery has recently been clarified: in the short-term there is no reduction in the number of postoperative myocardial infarction, deaths or hospital length of stay. Coronary artery revascularisation should be limited to these patients who have a well-defined need for the procedure, independent of the need of noncardiac surgery. Optimising medical therapy remains the best option for reducing perioperative complications in stable patients: the addition of statin therapy in candidates for noncardiac surgery with known or strongly suspected coronary disease may be conceived. There is compelling evidence for the use of beta-blockers in reducing cardiac risk. This review presents the studies that support the beneficial effect of beta-blockers, pharmacological effects and some practical aspects in noncardiac surgery. In the management of most of these patients, the use of beta-blockers can aid in the avoidance of a preoperative stress test. The remaining problem to solve is the cost-effective identification of the small group of patients in which the protective effect of beta-blocker therapy is insufficient and a cardiac revascularisation should be considered.
Related Concept Videos
Atherosclerosis III: Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease V: Postoperative Nursing Management
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Peripheral Artery Disease III: Interprofessional Care